The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Monoclonal Mouse Antibody Market Research Report 2024
Synopsis
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
The global Monoclonal Mouse Antibody market was valued at US$ 8986.6 million in 2023 and is anticipated to reach US$ 12110 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The key players are Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals and Seattle Genetics, etc, with about 57% market shares.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Mouse Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Mouse Antibody.
Report Scope
The Monoclonal Mouse Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monoclonal Mouse Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoclonal Mouse Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Segment by Type
IgM
IgG
IgA
Others
Segment by Application
Therapeutic
Research
Diagnostic
ELISA kits
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monoclonal Mouse Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monoclonal Mouse Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
The global Monoclonal Mouse Antibody market was valued at US$ 8986.6 million in 2023 and is anticipated to reach US$ 12110 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The key players are Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals and Seattle Genetics, etc, with about 57% market shares.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Mouse Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Mouse Antibody.
Report Scope
The Monoclonal Mouse Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monoclonal Mouse Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoclonal Mouse Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Segment by Type
IgM
IgG
IgA
Others
Segment by Application
Therapeutic
Research
Diagnostic
ELISA kits
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monoclonal Mouse Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monoclonal Mouse Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Monoclonal Mouse Antibody Market Overview
1.1 Product Overview and Scope of Monoclonal Mouse Antibody
1.2 Monoclonal Mouse Antibody Segment by Type
1.2.1 Global Monoclonal Mouse Antibody Market Value Comparison by Type (2024-2030)
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Others
1.3 Monoclonal Mouse Antibody Segment by Application
1.3.1 Global Monoclonal Mouse Antibody Market Value by Application: (2024-2030)
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.3.5 ELISA kits
1.4 Global Monoclonal Mouse Antibody Market Size Estimates and Forecasts
1.4.1 Global Monoclonal Mouse Antibody Revenue 2019-2030
1.4.2 Global Monoclonal Mouse Antibody Sales 2019-2030
1.4.3 Global Monoclonal Mouse Antibody Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Monoclonal Mouse Antibody Market Competition by Manufacturers
2.1 Global Monoclonal Mouse Antibody Sales Market Share by Manufacturers (2019-2024)
2.2 Global Monoclonal Mouse Antibody Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Monoclonal Mouse Antibody Average Price by Manufacturers (2019-2024)
2.4 Global Monoclonal Mouse Antibody Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Monoclonal Mouse Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Monoclonal Mouse Antibody, Product Type & Application
2.7 Monoclonal Mouse Antibody Market Competitive Situation and Trends
2.7.1 Monoclonal Mouse Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Monoclonal Mouse Antibody Players Market Share by Revenue
2.7.3 Global Monoclonal Mouse Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Monoclonal Mouse Antibody Retrospective Market Scenario by Region
3.1 Global Monoclonal Mouse Antibody Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Monoclonal Mouse Antibody Global Monoclonal Mouse Antibody Sales by Region: 2019-2030
3.2.1 Global Monoclonal Mouse Antibody Sales by Region: 2019-2024
3.2.2 Global Monoclonal Mouse Antibody Sales by Region: 2025-2030
3.3 Global Monoclonal Mouse Antibody Global Monoclonal Mouse Antibody Revenue by Region: 2019-2030
3.3.1 Global Monoclonal Mouse Antibody Revenue by Region: 2019-2024
3.3.2 Global Monoclonal Mouse Antibody Revenue by Region: 2025-2030
3.4 North America Monoclonal Mouse Antibody Market Facts & Figures by Country
3.4.1 North America Monoclonal Mouse Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Monoclonal Mouse Antibody Sales by Country (2019-2030)
3.4.3 North America Monoclonal Mouse Antibody Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Monoclonal Mouse Antibody Market Facts & Figures by Country
3.5.1 Europe Monoclonal Mouse Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Monoclonal Mouse Antibody Sales by Country (2019-2030)
3.5.3 Europe Monoclonal Mouse Antibody Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Monoclonal Mouse Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific Monoclonal Mouse Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Monoclonal Mouse Antibody Sales by Country (2019-2030)
3.6.3 Asia Pacific Monoclonal Mouse Antibody Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Monoclonal Mouse Antibody Market Facts & Figures by Country
3.7.1 Latin America Monoclonal Mouse Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Monoclonal Mouse Antibody Sales by Country (2019-2030)
3.7.3 Latin America Monoclonal Mouse Antibody Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Monoclonal Mouse Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Monoclonal Mouse Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Monoclonal Mouse Antibody Sales by Country (2019-2030)
3.8.3 Middle East and Africa Monoclonal Mouse Antibody Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Monoclonal Mouse Antibody Sales by Type (2019-2030)
4.1.1 Global Monoclonal Mouse Antibody Sales by Type (2019-2024)
4.1.2 Global Monoclonal Mouse Antibody Sales by Type (2025-2030)
4.1.3 Global Monoclonal Mouse Antibody Sales Market Share by Type (2019-2030)
4.2 Global Monoclonal Mouse Antibody Revenue by Type (2019-2030)
4.2.1 Global Monoclonal Mouse Antibody Revenue by Type (2019-2024)
4.2.2 Global Monoclonal Mouse Antibody Revenue by Type (2025-2030)
4.2.3 Global Monoclonal Mouse Antibody Revenue Market Share by Type (2019-2030)
4.3 Global Monoclonal Mouse Antibody Price by Type (2019-2030)
5 Segment by Application
5.1 Global Monoclonal Mouse Antibody Sales by Application (2019-2030)
5.1.1 Global Monoclonal Mouse Antibody Sales by Application (2019-2024)
5.1.2 Global Monoclonal Mouse Antibody Sales by Application (2025-2030)
5.1.3 Global Monoclonal Mouse Antibody Sales Market Share by Application (2019-2030)
5.2 Global Monoclonal Mouse Antibody Revenue by Application (2019-2030)
5.2.1 Global Monoclonal Mouse Antibody Revenue by Application (2019-2024)
5.2.2 Global Monoclonal Mouse Antibody Revenue by Application (2025-2030)
5.2.3 Global Monoclonal Mouse Antibody Revenue Market Share by Application (2019-2030)
5.3 Global Monoclonal Mouse Antibody Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Monoclonal Mouse Antibody Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Monoclonal Mouse Antibody Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Monoclonal Mouse Antibody Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Monoclonal Mouse Antibody Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AbbVie Monoclonal Mouse Antibody Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Amgen Monoclonal Mouse Antibody Product Portfolio
6.6.5 Amgen Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Monoclonal Mouse Antibody Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bayer Monoclonal Mouse Antibody Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Lilly
6.9.1 Lilly Corporation Information
6.9.2 Lilly Description and Business Overview
6.9.3 Lilly Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Lilly Monoclonal Mouse Antibody Product Portfolio
6.9.5 Lilly Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bristol-Myers Squibb Monoclonal Mouse Antibody Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Corporation Information
6.11.2 GlaxoSmithKline Monoclonal Mouse Antibody Description and Business Overview
6.11.3 GlaxoSmithKline Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.11.4 GlaxoSmithKline Monoclonal Mouse Antibody Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments/Updates
6.12 Biogen
6.12.1 Biogen Corporation Information
6.12.2 Biogen Monoclonal Mouse Antibody Description and Business Overview
6.12.3 Biogen Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Biogen Monoclonal Mouse Antibody Product Portfolio
6.12.5 Biogen Recent Developments/Updates
6.13 AstraZeneca
6.13.1 AstraZeneca Corporation Information
6.13.2 AstraZeneca Monoclonal Mouse Antibody Description and Business Overview
6.13.3 AstraZeneca Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.13.4 AstraZeneca Monoclonal Mouse Antibody Product Portfolio
6.13.5 AstraZeneca Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Corporation Information
6.14.2 Sanofi Monoclonal Mouse Antibody Description and Business Overview
6.14.3 Sanofi Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sanofi Monoclonal Mouse Antibody Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Alexion Pharmaceuticals
6.15.1 Alexion Pharmaceuticals Corporation Information
6.15.2 Alexion Pharmaceuticals Monoclonal Mouse Antibody Description and Business Overview
6.15.3 Alexion Pharmaceuticals Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Alexion Pharmaceuticals Monoclonal Mouse Antibody Product Portfolio
6.15.5 Alexion Pharmaceuticals Recent Developments/Updates
6.16 Seattle Genetics
6.16.1 Seattle Genetics Corporation Information
6.16.2 Seattle Genetics Monoclonal Mouse Antibody Description and Business Overview
6.16.3 Seattle Genetics Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Seattle Genetics Monoclonal Mouse Antibody Product Portfolio
6.16.5 Seattle Genetics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Monoclonal Mouse Antibody Industry Chain Analysis
7.2 Monoclonal Mouse Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Monoclonal Mouse Antibody Production Mode & Process
7.4 Monoclonal Mouse Antibody Sales and Marketing
7.4.1 Monoclonal Mouse Antibody Sales Channels
7.4.2 Monoclonal Mouse Antibody Distributors
7.5 Monoclonal Mouse Antibody Customers
8 Monoclonal Mouse Antibody Market Dynamics
8.1 Monoclonal Mouse Antibody Industry Trends
8.2 Monoclonal Mouse Antibody Market Drivers
8.3 Monoclonal Mouse Antibody Market Challenges
8.4 Monoclonal Mouse Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
